Differential	differential	O	O
effects	effects	O	O
of	of	O	O
systemically	systemically	O	O
administered	administered	O	O
ketamine	ketamine	S_chemical	O
and	and	O	O
lidocaine	lidocaine	S_chemical	O
on	on	O	O
dynamic	dynamic	O	O
and	and	O	O
static	static	O	O
hyperalgesia	hyperalgesia	O	S_disease
induced	induced	O	O
by	by	O	O
intradermal	intradermal	O	O
capsaicin	capsaicin	S_chemical	O
in	in	O	O
humans	humans	O	O
.	.	O	O

We	we	O	O
have	have	O	O
examined	examined	O	O
the	the	O	O
effect	effect	O	O
of	of	O	O
systemic	systemic	O	O
administration	administration	O	O
of	of	O	O
ketamine	ketamine	S_chemical	O
and	and	O	O
lidocaine	lidocaine	S_chemical	O
on	on	O	O
brush-evoked	brush-evoked	O	O
(	(	O	O
dynamic	dynamic	O	O
)	)	O	O
pain	pain	O	S_disease
and	and	O	O
punctate-evoked	punctate-evoked	O	O
(	(	O	O
static	static	O	O
)	)	O	O
hyperalgesia	hyperalgesia	O	S_disease
induced	induced	O	O
by	by	O	O
capsaicin	capsaicin	S_chemical	O
.	.	O	O

In	in	O	O
a	a	O	O
randomized	randomized	O	O
,	,	O	O
double-blind	double-blind	O	O
,	,	O	O
placebo-controlled	placebo-controlled	O	O
,	,	O	O
crossover	crossover	O	O
study	study	O	O
,	,	O	O
we	we	O	O
studied	studied	O	O
12	12	O	O
volunteers	volunteers	O	O
in	in	O	O
three	three	O	O
experiments	experiments	O	O
.	.	O	O

Capsaicin	capsaicin	S_chemical	O
100	100	O	O
micrograms	micrograms	O	O
was	was	O	O
injected	injected	O	O
intradermally	intradermally	O	O
on	on	O	O
the	the	O	O
volar	volar	O	O
forearm	forearm	O	O
followed	followed	O	O
by	by	O	O
an	an	O	O
i.v	i.v	O	O
.	.	O	O

infusion	infusion	O	O
of	of	O	O
ketamine	ketamine	S_chemical	O
(	(	O	O
bolus	bolus	O	O
0.1	0.1	O	O
mg	mg	O	O
kg-1	kg-1	O	O
over	over	O	O
10	10	O	O
min	min	O	O
followed	followed	O	O
by	by	O	O
infusion	infusion	O	O
of	of	O	O
7	7	O	O
micrograms	micrograms	O	O
kg-1	kg-1	O	O
min-1	min-1	O	O
)	)	O	O
,	,	O	O
lidocaine	lidocaine	S_chemical	O
5	5	O	O
mg	mg	O	O
kg-1	kg-1	O	O
or	or	O	O
saline	saline	O	O
for	for	O	O
50	50	O	O
min	min	O	O
.	.	O	O

Infusion	infusion	O	O
started	started	O	O
15	15	O	O
min	min	O	O
after	after	O	O
injection	injection	O	O
of	of	O	O
capsaicin	capsaicin	S_chemical	O
.	.	O	O

The	the	O	O
following	following	O	O
were	were	O	O
measured	measured	O	O
:	:	O	O
spontaneous	spontaneous	O	O
pain	pain	O	S_disease
,	,	O	O
pain	pain	O	S_disease
evoked	evoked	O	O
by	by	O	O
punctate	punctate	S_chemical	O
and	and	O	O
brush	brush	O	O
stimuli	stimuli	O	O
(	(	O	O
VAS	vas	O	O
)	)	O	O
,	,	O	O
and	and	O	O
areas	areas	O	O
of	of	O	O
brush-evoked	brush-evoked	O	O
and	and	O	O
punctate-evoked	punctate-evoked	O	O
hyperalgesia	hyperalgesia	O	S_disease
.	.	O	O

Ketamine	ketamine	S_chemical	O
reduced	reduced	O	O
both	both	O	O
the	the	O	O
area	area	O	O
of	of	O	O
brush-evoked	brush-evoked	O	O
and	and	O	O
punctate-evoked	punctate-evoked	O	O
hyperalgesia	hyperalgesia	O	S_disease
significantly	significantly	O	O
and	and	O	O
it	it	O	O
tended	tended	O	O
to	to	O	O
reduce	reduce	O	O
brush-evoked	brush-evoked	O	O
pain	pain	O	S_disease
.	.	O	O

Lidocaine	lidocaine	S_chemical	O
reduced	reduced	O	O
the	the	O	O
area	area	O	O
of	of	O	O
punctate-evoked	punctate-evoked	O	O
hyperalgesia	hyperalgesia	O	S_disease
significantly	significantly	O	O
.	.	O	O

It	it	O	O
tended	tended	O	O
to	to	O	O
reduce	reduce	O	O
VAS	vas	O	O
scores	scores	O	O
of	of	O	O
spontaneous	spontaneous	O	O
pain	pain	O	S_disease
but	but	O	O
had	had	O	O
no	no	O	O
effect	effect	O	O
on	on	O	O
evoked	evoked	O	O
pain	pain	O	S_disease
.	.	O	O

The	the	O	O
differential	differential	O	O
effects	effects	O	O
of	of	O	O
ketamine	ketamine	S_chemical	O
and	and	O	O
lidocaine	lidocaine	S_chemical	O
on	on	O	O
static	static	O	O
and	and	O	O
dynamic	dynamic	O	O
hyperalgesia	hyperalgesia	O	S_disease
suggest	suggest	O	O
that	that	O	O
the	the	O	O
two	two	O	O
types	types	O	O
of	of	O	O
hyperalgesia	hyperalgesia	O	S_disease
are	are	O	O
mediated	mediated	O	O
by	by	O	O
separate	separate	O	O
mechanisms	mechanisms	O	O
and	and	O	O
have	have	O	O
a	a	O	O
distinct	distinct	O	O
pharmacology	pharmacology	O	O
.	.	O	O

